Toan C. Ong

机构：Colorado School of Public Health, University of Colorado Anschutz · ORCID：0000-0001-6787-1407

发表论文 130 篇 · 总被引 5084 次 · h-index 31

代表论文

• Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis (2024 · The Lancet · 被引 132)
• Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025 (2025 · MMWR Morbidity and Mortality Weekly Report · 被引 90)
• Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024 (2024 · MMWR Morbidity and Mortality Weekly Report · 被引 81)
• Interim Estimates of 2024–2025 Seasonal Influenza Vaccine Effectiveness — Four Vaccine Effectiveness Networks, United States, October 2024–February 2025 (2025 · MMWR Morbidity and Mortality Weekly Report · 被引 71)
• Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions — VISION Network, September 2023–February 2024 (2024 · MMWR Morbidity and Mortality Weekly Report · 被引 38)
• Influenza Vaccine Effectiveness Against Hospitalizations and Emergency Department or Urgent Care Encounters for Children, Adolescents, and Adults During the 2023–2024 Season, United States (2024 · Clinical Infectious Diseases · 被引 27)